Mapping of tissue tropism determinants in coxsackievirus genomes

References

1. Andino R., Böddeker N., Silvera D., Gamarnik A. V. 1999; Intracellular determinants of picornavirus replication. Trends in Microbiology 7:76–82
   [Google Scholar]
2. Arola A., Kalimo H., Ruuskanen O., Hyypiä T. 1995; Experimental myocarditis induced by two different coxsackievirus B3 variant: aspects of pathogenesis and comparison of diagnostic methods. Journal of Medical Virology 47:251–259
   [Google Scholar]
3. Bergelson J. M., Mohanty J. G., Crowell R. L., St John N. F., Lublin D. M., Fingerg R. W. 1995; Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). Journal of Virology 69:1903–1906
   [Google Scholar]
4. Bergelson J. M., Cunningham J. A., Droguett G., Kurt-Jones E. A., Krithivas A., Hong J. S., Horwitz M. S., Crowell R. L., Finberg R. W. 1997; Isolation of common receptor for coxsackie B viruses and adenovirus 2 and 5. Science 275:1320–1323
   [Google Scholar]
5. Bergelson J. M., Krithivas A., Celi L., Droguett G., Horwitz M. S., Wickham T., Crowell R. L., Finberg R. W. 1998; The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. Journal of Virology 72:415–419
   [Google Scholar]
6. Caggana M., Chan P., Ramsingh A. 1993; Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. Journal of Virology 67:4797–4803
   [Google Scholar]
7. Chang K. H., Auvinen P., Hyypiä T., Stanway G. 1989; The nucleotide sequence of coxsackievirus A9 – implication for receptor binding and enterovirus classification. Journal of General Virology 70:3269–3280
   [Google Scholar]
8. Chapman N. M., Ragland A., Leser J. S., Höfling K., Willian S., Semler B. L., Tracy S. 2000; A group B coxsackievirus/poliovirus 5′ nontranslated region chimera can act as an attenuated vaccine strain in mice. Journal of Virology 74:4047–4056
   [Google Scholar]
9. Dalldorf G., Melnick J. L. 1965; Coxsackieviruses. In Viral and Rickettsial Infections on Man pp 472–512 Edited by Horsfall F. L., Tamm I. Philadelphia: Lippincott;
   [Google Scholar]
10. Dunn J. J., Chapman N. M., Tracy S., Romero J. R. 2000; Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5′ nontranslated region. Journal of Virology 74:4787–4794
    [Google Scholar]
11. Evans D. M. A., Dunn G., Minor P. D., Schild G. C., Cann A. J., Stanway G., Almond J. W., Currey K., Maizel J. V. 1985; A single nucleotide change in the 5′ non-coding region of the genome of the Sabin type 3 poliovaccine is associated with increased neurovirulence. Nature 314:548–550
    [Google Scholar]
12. Evans J. D., Almond W. J. 1998; Cell receptors for picornaviruses as determinants of cell tropism and pathogenesis. Trends in Microbiology 6:198–202
    [Google Scholar]
13. Freistadt M. S., Fleit H. B., Wimmer E. 1993; Poliovirus receptor on human blood cells: a possible extraneural site of poliovirus replication. Virology 195:798–803
    [Google Scholar]
14. Gamarnik A. V., Andino R. 2000; Interactions of viral protein 3CD and poly(rC) binding protein with the 5′ untranslated region of the poliovirus genome. Journal of Virology 74:2219–2226
    [Google Scholar]
15. Grist N. R., Bell E. J., Assaad F. 1978; Enteroviruses in human disease. Progress in Medical Virology 24:114–157
    [Google Scholar]
16. Gromeier M., Bossert B., Arita M., Nomoto A., Wimmer E. 1999; Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. Journal of Virology 73:958–964
    [Google Scholar]
17. Gromeier M., Solecki D., Patel D. D., Wimmer E. 2000; Expression of the human poliovirus receptor/CD155 gene during development of the central nervous system: implications for the pathogenesis of poliomyelitis. Virology 273:248–257
    [Google Scholar]
18. Hovi T., Stenvik M., Rosenlew M. 1996; Relative abundance of enterovirus serotypes in sewage differs from that in patients: clinical and epidemiological implications. Epidemiology and Infection 116:91–97
    [Google Scholar]
19. Hughes P., Horsnell C., Hyypiä T., Stanway G. 1995; The coxsackievirus A9 RGD motif is not essential for virus viability. Journal of Virology 69:8035–8040
    [Google Scholar]
20. Hyypiä T., Kallajoki M., Maaronen M., Stanway G., Kandolf R., Auvinen P., Kalimo H. 1993; Pathogenetic differences between coxsackie A and B virus infections in newborn mice. Virus Research 27:71–78
    [Google Scholar]
21. Hyypiä T., Hovi T., Knowles N. J., Stanway G. 1997; Classification of enteroviruses based on molecular and biological properties. Journal of General Virology 78:1–11
    [Google Scholar]
22. Kandolf R., Hofschneider P. H. 1985; Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proceedings of the National Academy of Sciences, USA 82:4818–4822
    [Google Scholar]
23. King A. M. Q., Brown F., Christian P., Hovi T., Hyypiä T., Knowles N. J., Lemon S. P., Minor P. D., Palmenberg A. C., Skern T., Stanway G. 2000; Picornaviridae. In Virus taxonomy. Seventh Report of the International Committee on Taxonomy of Viruses pp 657–673 Edited by van Regenmortel M. H. V., Fauquet C. M., Bishop D. H. L., Carstens E. B., Estes M. K., Lemon S. M., Maniloff J., Mayo M. A., McGeoch D. J., Pringle C. R., Wickner R. B. San Diego: Academic Press;
    [Google Scholar]
24. Klump W. M., Bergmann I., Muller B. C., Ameis D., Kandolf R. 1990; Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5′ uridine residues are regained during plus-strand RNA synthesis. Journal of Virology 64:1573–1583
    [Google Scholar]
25. Knowlton K. U., Jeon E. S., Berkley N., Wessely R., Huber S. 1996; A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. Journal of Virology 70:7811–7818
    [Google Scholar]
26. Koike S., Taya S., Kurata T., Abe S., Ise I., Yonekawa H., Nomoto A. 1991; Transgenic mice susceptible to poliovirus. Proceedings of the National Academy of Sciences, USA 88:951–955
    [Google Scholar]
27. Lindberg A. M., Crowell R. L., Zell R., Kandolf R., Petterson U. 1992; Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3. Virus Research 24:187–196
    [Google Scholar]
28. Mena I., Fischer C., Gebhard J. R., Perry C. M., Harkins S., Whitton J. L. 2000; Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology 271:276–288
    [Google Scholar]
29. Minor D. P. 1992; The molecular biology of poliovaccines. Journal of Virology 73:3065–3077
    [Google Scholar]
30. Moore M., Morens D. M. 1984; Enteroviruses, including polioviruses. In Textbook of Virology pp 407–483 Edited by Belshe R. B. Massachusetts: PGS Publishing Company;
    [Google Scholar]
31. Pulli T., Koskimies P., Hyypiä T. 1995; Molecular comparison of coxsackie A virus serotypes. Virology 212:30–38
    [Google Scholar]
32. Ramsingh A., Collins D. N. 1995; A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence. Journal of Virology 69:7278–7281
    [Google Scholar]
33. Ren R., Racaniello V. 1992; Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. Journal of Virology 66:296–304
    [Google Scholar]
34. Ren R., Constantini F., Gorgacz E. J., Lee J. J., Racaniello V. R. 1990; Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63:353–362
    [Google Scholar]
35. Ren R., Ross E. G., Racaniello V. R. 1991; Identification of two determinants that attenuate vaccine-related type 2 poliovirus. Journal of Virology 65:1377–1380
    [Google Scholar]
36. Rinehart J. E., Gómez R. M., Roos R. P. 1997; Molecular determinants for virulence in coxsackievirus B1 infection. Journal of Virology 71:3986–3991
    [Google Scholar]
37. Roivainen M., Hyypiä T., Piirainen L., Kalkkinen N., Stanway G., Hovi T. 1991; RGD-dependent entry of coxsackievirus A9 into host cell and its bypass after cleavage of VP1 protein by intestinal proteases. Journal of Virology 65:4735–4740
    [Google Scholar]
38. Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T., Heino J., Hyypiä T. 1994; Entry of coxsackievirus A9 into host cells: specific interactions with αvβ3 integrin, the virtonectin receptor. Virology 203:357–365
    [Google Scholar]
39. Santti J., Hyypiä T., Kinnunen L., Salminen M. 1999; Evidence of recombination among enteroviruses. Journal of Virology 73:8741–8749
    [Google Scholar]
40. Santti J., Harvala H., Kinnunen L., Hyypiä T. 2000; Molecular epidemiology and evolution of coxsackievirus A9. Journal of General Virology 81:1361–1372
    [Google Scholar]
41. Schmidtke M., Selinka H. C., Heim A., Jahn B., Tonew M., Kandolf R., Stelzner A., Zell R. 2000; Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotype differences to capsid protein VP1. Virology 275:77–88
    [Google Scholar]
42. Svitkin Y. V., Cammack N., Minor P. D., Almond J. 1990; Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C₄₇₂→U. Virology 175:103–109
    [Google Scholar]
43. Tu Z., Chapman N. M., Hufnagel G., Tracy S., Romero J. R., Barry W. H., Zhao L., Currey K., Shapiro B. 1995; The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ nontranslated region. Journal of Virology 69:4607–4618
    [Google Scholar]
44. Waris M., Ziegler T., Kivivirta M., Ruuskanen O. 1990; Rapid detection of respiratory syncytial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies. Journal of Clinical Microbiology 28:1159–1162
    [Google Scholar]